Transparency Market Research has published a new report, titled “Newborn Screening Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.” According to the report, the global newborn screening market is riding on the back of vulnerability of newborns to catch different types of infections right from the first day of their lives. Newborn screening acts as a preventive paediatric screening test which can diagnose abnormalities and congenital abnormalities of a baby so as to identify diseases which maybe gripping them.
Newborn screening has become a must today as it can bring about early detection of serious genetic diseases which is very likely to result in future disabilities or even death if untreated during the initial stage itself. With the diagnosis of diseases through newborn screening, doctors are able to carry out a treatment in order to save the baby in the first week itself, in an attempt to reverse the prognosis. The market for newborn screening is anticipated to expand at a rapid pace in the years to come on account of the growing realization that early diagnosis and treatment can help reduce mortality, morbidity, and disabilities in children.
The global newborn screening market is flourishing on account of the rising incidences of neonatal diseases as well as increasing efforts taken by government to create awareness regarding the importance of early diagnosis of neonatal diseases. Government across the globe are also funding for newborn screening which is favouring the growth of the market. Technological advancements and efforts by market players will ensure the continued progress of the global newborn screening Market.
However, the unavailability of advanced tests and technologically superior instruments, stringent regulations in a few countries, and delays in hospitalizations are some of the factors that are restricting the growth of the global newborn screening market. On a brighter note however, private investors are investing in newborn screening programs in developing nations and this partnership with hospitals and diagnostic centers by private investors will drive the growth opportunity of the newborn screening market in developing nations.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4581
On the basis of geography, the global newborn screening market is segmented into Asia Pacific, Latin America, Europe, the Middle East and Africa, and North America. Leaving all other regions behind, North America accounts for the lion’s share of the newborn screening market. The introduction of new test methods, technological advancements in screening, and government initiatives for promoting newborn screening are some of the factors that are driving the growth of the North America newborn screening market. Another region which is anticipated to witness a staggering growth in the years to come is Asia Pacific. The growing incidences of premature births as well as the rising awareness regarding the benefits of early diagnosis of genetic diseases in the newborns are driving the growth of the newborn screening market in Asia Pacific.
On the basis of product, the global newborn screening market is segmented into assay kits and instruments. The immunoassay kits which is a sub segment of the assay kits segment is predicted to lead to other forecast period. In terms of end-user, this market is segmented into specialty clinics, diagnostic centres, maternity clinics, hospitals. It is forecasted that the hospitals and diagnostic centre segments will hold dominating shares within the market, driven by increasing number of premature births.
The report profiles leading vendors operating within the global newborn screening market for the purpose of study. They are: PerkinElmer Inc., GE Healthcare, Thermo Fisher Scientific Inc., Bio Rad Laboratories, Inc., ZenTech S.A., Trivitron Healthcare, Agilent Technologies, Medtronic, MP Biomedicals LLC, and Natus Medical Incorporated.